Canaccord analyst John Newman was out pounding the table on Kite Pharma Inc (NASDAQ:KITE), reiterating a Buy rating and price target of $90, …
Canaccord Genuity analyst John Newman came out today with some cautious stance on Agios Pharmaceuticals Inc (NASDAQ:AGIO), as the company will present data for AG-120 in …
In a research report released Tuesday, Canaccord analyst John Newman reiterated a Buy rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a price target of …
In a research report issued Friday, Canaccord Genuity analyst John Newman reiterated a Buy rating on Celgene Corporation (NASDAQ:CELG) and raised the price target …
In a research report issued today, Canaccord Genuity analyst John Newman raised his earnings estimates for Celgene Corporation (NASDAQ:CELG) based on higher 2015 and 2020 …
Canaccord Genuity analyst John Newman came out today with a research report on Agios Pharmaceuticals Inc (NASDAQ:AGIO), reducing the price target to $93 (from $103), …
Ahead of the bell, Palatin Technologies, Inc. (NYSEMKT:PTN) shares have popped 51%, following today’s news that the FDA advisory committee voted 18-6 in …
Canaccord Genuity analyst John Newman was out pounding the table on Celgene Corporation (NASDAQ:CELG) Thursday, reiterating a Buy rating and price target of $156, which …
In a research report issued today, Canaccord Genuity analyst John Newman reiterated a Buy rating on Kite Pharma Inc (NASDAQ:KITE) with a price …
The first quarter of 2015 has come to a close and companies are still releasing earnings reports. Let’s look back and see which …
